跳至主要内容
临床试验/ACTRN12626000928314
ACTRN12626000928314进行中(未招募)不适用

A randomised controlled trial to evaluate the BLOOM program, a digital intervention integrating social and emotional learning, physical activity, and nutrition, in early childhood education and care settings to enhance preschoolers’ self-regulation and wellbeing

Deakin University0 个研究点目标入组 448 人开始时间: 2026年8月7日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
448

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
3 Years 至 65 Years(—)
性别
All

入选标准

  • ECEC services will be eligible if: i) they enrol at least 40 children aged between 3-5 years and ii) have internet access. ECEC educators who report previously accessing the PRSIST program website will still be eligible to participate given the additional components offered as part of the BLOOM program, however, we will assess how long ago educators accessed this program.
  • ECEC educators will be eligible to participate if they are primarily working in the room that caters to 3-6 years olds in a consenting ECEC service.
  • Children will be eligible if they: i) are 3-5 years during recruitment; ii) parents have provided informed consent for participation and report attending this ECEC at least 2 days/week; and, iv) have parental consent. If a family has more than one eligible child, both will be eligible for inclusion but parents will receive the intervention once.
  • Parents of children will be eligible to participate if they: i) have a mobile phone with web capabilities (e.g. 4G/5G) and ii) can understand English sufficiently to engage with the intervention.

排除标准

  • Mobile preschools, home-based care, Department of Education services and services who cater exclusively for children requiring specialist care will be excluded (<5 % of services).
  • Parents who report previously engaging with the Daily Growth app in the past six months will be ineligible to participate.

研究者

相似试验

The BLOOM program - testing the impact of an online... | 临床试验